Abstract
Introduction
Glucagon-like peptide-1 (GLP-1), a gut incretin hormone secreted from L cells in the intestine in response to food intake, has currently been considered as an attractive agent for the management of type-2 diabetes mellitus (T2DM) [1] , and the GLP-1 receptor agonist-exendin-4 (Ex-4), which is a 39 amino acid peptide, activates GLP-1 receptors to increase intracellular cAMP in pancreatic acinar cells and has no effect on VIP receptors and function as well as GLP-1. So far, there is emerging evidence that GLP-1 and Ex-4 could provide beneficial effects for cardiovascular diseases in both experimental models and patients [2] [3] [4] [5] . Recently, Chinda et al. [6] showed that dipeptidyl peptidase-4 inhibitor, a drug for postponing the degradation of GLP-1, could provide an anti-arrhythmic effect during myocardial ischemia (MI), indicating that GLP-1 or GLP-1 receptor agonist may provide an anti-arrhythmic effect during MI.
Mitochondrial ATP-sensitive potassium (K ATP ) channels have been shown to be a mediator or trigger of ischemic preconditioning or pharmacological preconditioning during MI-reperfusion injury [7] [8] [9] . Recently, mitochondrial K ATP channels was shown to be involved in the anti-arrhythmic effects of ischemic preconditioning and pharmacological preconditioning during acute MI [10] [11] [12] . Thus, we hypothesized that GLP-1 receptor agonist-Ex-4 may provide an antiarrhythmic effect via mitochondrial K ATP channels. This hypothesis was tested in a rat MI model in the present study.
Methods

Animal preparation and experimental designs
The experimental protocol conformed to the Guideline for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, revised 1996) and was approved by Institutional Animal Care and Use Committee. A total of 40 male Sprague Dawley rats (250-300 g) were randomly assigned into 4 groups receiving the following treatments: Group 1 -MI (n = 10): the rats were subjected to left anterior descending coronary artery occlusion for 30 min, 1 h before coronary artery occlusion, the rats were once treated with sterile saline; Group 2 -MI + + Ex-4 (MI + Ex-4) (n = 10): the rats were once treated with Ex-4 (5 µg/kg, i.v., Sigma, USA) [13] 1 h before left anterior descending coronary artery occlusion. The Ex-4 was dissolved in sterile saline; Group 3 -MI + Ex-4 + 5-hydroxydecanoic acid (MI-Ex-4-5-HD) (n = 10): after rats were treated with Ex-4, 5-HD (a specific of mitochondrial K ATP channels inhibitor, 10 mg/kg, i.v., Sigma, USA) [11] was once injected 10 min before left anterior descending coronary artery occlusion. The 5-HD was dissolved in sterile saline; Group 4 -MI + 5-HD (MI-5-HD) (n = 10): 5-HD (10 mg/kg, i.v.) was once injected 10 min before left anterior descending coronary artery occlusion.
After being anesthetized with sodium pentobarbital (45 mg/kg, i.p.), the rats were ventilated artificially with a volume-controlled rodent respirator at 70 strokes per minute. All rats were placed on an electric heating pad to maintain their body temperature at 37°C. Heparin (200 IU/kg, i.v.) was given before ischemia. The right common carotid artery and left jugular vein were cannulated to measure mean arterial blood pressure (MBP) and administrate saline or drugs, respectively. Lead II of the electrocardiogram was monitored with subcutaneous stainless steel electrodes. A computerbased EP system (LEAD2000B, Jinjiang Ltd, China) was used for recording MBP, heart rate and electrocardiogram.
A thoracotomy through a left parasternal incision was performed. The pericardium was incised, and the anterior wall of the left ventricle was exposed. A 4-0 silk suture on a small curved needle was passed through the myocardium beneath the middle segment of the left anterior descending coronary artery occlusion branch crossing down the middle of the anterior wall of the left ventricle. A successful MI model was confirmed by ST segment elevation in leads II and regional cyanosis of the myocardial surface.
Assessment of ventricular arrhythmias
Ischemia-induced ventricular arrhythmias were determined in accordance with the Lambeth Conventions [11, 12] . Ventricular ectopic beat (VEB) was defined as identifiable premature QRS complexes (premature with respect to the P wave). Ventricular tachycardia (VT) was defined as the occurrence of four or more consecutive VEBs at a rate faster than the resting sinus rate. Ventricular fibrillation (VF) was defined as unidentifiable and low voltage QRS complexes. Other patterns of VEBs such as bigeminy, couplet (two consecutive VEBs) and salvos (three consecutive VEBs) were included in VEBs and not analyzed separately. VF may be sustained or may convert spontaneously to a normal sinus rhythm. VF resulting in death was considered as irreversible (Fig. 1) .
The severity of arrhythmias was quantified by the following scoring system [11, 12] : -0: 0-50 VEBs with no other arrhythmias during the 30-min ischemia period, -1: only 50-500 VEBs, -2: more than 500 VEBs, or one episode of spontaneously reversible VT or VF, -3: 2-30 episodes of spontaneously reversible VT and/or VF, 
Statistical analysis
All values were expressed as mean ± SD or median (interquartile range) for continuous variables or the percentage of incidence of ventricular arrhythmia. One-way ANOVA or Welch was used for comparisons among groups and the StudentNeuman-Keuls or Dunnett T3 was used for posthoc multiple comparisons. Paired samples t test was used for comparisons of heart rate and MBP within each group. Mann-Whitney U test was used for arrhythmia score between two groups; when more than two groups were compared, Kruskale-Wallis H test was used. Incidences of ventricular arrhythmias (i.e. VT and VF) were used for comparisons by Fisher's exact test. Statistical significance was defined as p < 0.05.
Results
Hemodynamics
There were no significant differences in heart rate and MBP among each group (p > 0.05 for all). Heart rate and MBP after 30-min ligation were slightly lower than those before 30-min ligation, but no statistical significances were found (p > 0.05 for all; Table 1 ).
Ventricular arrhythmias during ischemia
In this MI model, severe ventricular arrhythmias peaked at 5-25 min after coronary artery ligation. Figure 1 shows different ventricular arrhythmias during the 30-min ischemia.
Incidences of VT and VF
The incidence of VF (1/10, 10.0%) in MI-Ex-4 group was significantly decreased compared to that in MI group (7/10, 70.0%; p < 0.05); however, there was no significant difference in VT incidence (9/10, 90.0% vs. 10/10, 100% in MI group; p > 0.05). Administration of 5-HD could abolish the protective effect of Ex-4 on VF (6/10, 60.0%; p < 0.05). 5-HD alone did not affect the incidences of VT and VF during acute MI compared to those in MI group, respectively (p > 0.05 for all; Fig. 2 ).
Durations of VT + VF
The duration of VT + VF in MI-Ex-4 group (24.8 ± 10.5 s) was significantly shorter than that in MI group (78.4 ± 21.9 s; p < 0.05). Administration of 5-HD abolished the effects of Ex-4 on duration of VT + VF (71.3 ± 19.7 s) compared to that in MI-Ex-4 group (p < 0.05). 5-HD alone did not affect the duration of VT + VF during acute MI compared to that in MI group, respectively (p > 0.05; Fig. 3 ). Data were expressed as mean ± SD. There were no significant differences in heart rate and MBP among each group. Heart rate and MBP after 30-min ligation were lower than those before 30-min ligation, but no statistical significance were found (all p > 0. 
Number of episodes of VF + VT and VEBs/min
The number of episodes of VT + VF and VEBs/ /min in MI-Ex-4 group (19.8 ± 9.8 and 2.2 ± 0.9) were significantly decreased compared to those in MI group (45.5 ± 11.3 and 6.9 ± 1.9; p < 0.05). Administration of 5-HD could abolish the protective effects of Ex-4 on the number of episodes of VT + + VF (41.4 ± 7.9) and VEBs/min (7.0 ± 2.1) compared to those in MI-Ex-4 group (p < 0.05 for both). 5-HD alone did not affect the number of episodes of VT + + VF and VEBs/min during acute MI compared to those in MI group, respectively (p > 0.05 for both; Fig. 3 ).
Severity of arrhythmias
The severity of ventricular arrhythmias was significantly attenuated by Ex-4 (3.00 [median], 2.25-3.00 [interquartile range]) compared to that in MI group (4.00, 4.00-4.00) (p < 0.05). Administration of 5-HD (4.00, 4.00-4.00) abolished the anti-arrhythmic effect of Ex-4 on the severity of ventricular arrhythmias compared to that in MI-Ex-4 (p < 0.05). 5-HD alone did not affect the severity of ventricular arrhythmias during acute MI compared to that in MI group, respectively (both p > 0.05; Fig. 4 ).
Discussion
In this study, we found that Ex-4 could attenuate ischemia-induced ventricular arrhythmias in rats. Meanwhile, 5-HD, a specific inhibitor of mitochondrial K ATP channels could abolish the anti-arrhythmic effect of Ex-4. Thus, we speculated that Ex-4 could attenuate ischemia-induced ventricular arrhythmias by mediating mitochondrial K ATP channels.
Previous studies showed that GLP-1 and GLP-1 receptor agonists could reduce MI-reperfusion injury and improve cardiac function [2] [3] [4] [5] 14] . Recently, Chinda et al. [6] firstly showed that dipeptidyl peptidase-4 inhibitor, a drug for postponing the degradation of GLP-1 and could promote GLP-1 to exert more longer protective effect during MI, could attenuated the shortening of the effective refractory period, decreased the number of ventricular premature beats, increased the VF threshold, suggesting that GLP-1 could decrease ischemia-induced ventricular arrhythmias. In the present study, we found that Ex-4, a GLP-1 receptor agonist, could also attenuate the genesis of ventricular arrhythmias during MI without affecting hemodynamics. Yamamoto et al. [15] showed that GLP-1 receptor stimulation including Ex-4 could increase blood pressure and heart rate in a dose dependent, however, these affection only last little time and could return to basal levels within 40-50 min. In this study, we inject Ex-4 1 h before ischemia, thus, Ex-4 did not affect the hemodynamics during MI period. These further indicated that GLP-1 and its receptor agonists may provide an anti-arrhythmic effect during MI.
Mitochondrial K ATP channels was involved in the anti-arrhythmic effect of ischemic preconditioning or pharmacological preconditioning during MI [7] [8] [9] . In this study, we found that 5-HD, a specific inhibitor of mitochondrial K ATP channels could abo- lish the anti-arrhythmic effect of Ex-4, indicating that mitochondrial K ATP channels may be involved in the anti-arrhythmic effect of Ex-4. Many studies showed that activation of mitochondrial K ATP channels could limit mitochondrial Ca 2+ overload and maintain mitochondrial Ca 2+ homeostasis during MI [16, 17] ; mitochondrial Ca 2+ homeostasis plays a fundamental role in cytosolic free Ca 2+ homeostasis and could prevent ischemia-induced cytosolic free Ca 2+ overload [18, 19] which plays an important role in ischemia-induced ventricular arrhythmias [20] . Thus, mitochondrial K ATP channels was involved in the anti-arrhythmic effect of Ex-4 during MI.
Limitations of the study
In the study, we only investigated the effect of Ex-4 on ischemia-induced ventricular arrhythmias and observed that the specific inhibitor of mitochondrial K ATP channels could abolish the anti-arrhythmic effect of Ex-4. The precise mechanisms underlying our observation and their clinical relevance will require future elucidation. We need to investigate the effect of Ex-4 the change of intracellular Ca 2+ concentration or Ca 2+ channels in the future study.
Conclusions
The present study suggested that Ex-4 could attenuate ischemia-induced ventricular arrhythmias in rats which may be through mediating mitochondrial K ATP channels.
